1. Schut, J. and W. Haymaker, A pathologic study of five cases of common ancestry. JNeuropath Clin Neurol, 1951. 1: p. 183–213.
2. Matilla-Dueñas, A., R. Goold, and P. Giunti, Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1. Cerebellum, 2008. 7(2): p. 106-14.
3. Orr, H.T., et al., Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet, 1993. 4(3): p. 221-6.
4. Chung, M.Y., et al., Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat Genet, 1993. 5(3): p. 254-8.
5. Zoghbi, H.Y. and H.T. Orr, Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J Biol Chem, 2009. 284(12): p. 7425-9.
6. Kraus-Perrotta, C. and S. Lagalwar, Expansion, mosaicism and interruption: mechanisms of the CAG repeat mutation in spinocerebellar ataxia type 1. Cerebellum Ataxias, 2016. 3: p. 20.
7. Skinner, P.J., et al., Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature, 1997. 389(6654): p. 971-4.
8. Klement, I.A., et al., Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell, 1998. 95(1): p. 41-53.
9. Watase, K., et al., A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron, 2002. 34(6): p. 905-19.
10. Cummings, C.J., et al., Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron, 1999. 24(4): p. 879-92.
11. Iwata, A., et al., Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc Natl Acad Sci U S A, 2005. 102(37): p. 13135-40.
12. Berger, Z., et al., Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet, 2006. 15(3): p. 433-42.
13. Kohiyama, M.F. and S. Lagalwar, Stabilization and Degradation Mechanisms of Cytoplasmic Ataxin-1. J Exp Neurosci, 2015. 9(Suppl 2): p. 123-9.
14. Lasagna-Reeves, C.A., et al., A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1. Elife, 2015. 4.
15. Lasagna-Reeves, C.A., et al., Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes. Elife, 2015. 4.
16. Park, J., et al., RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Nature, 2013. 498(7454): p. 325-31.
17. Ferro, A., et al., Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model. PLoS One, 2017. 12(12): p. e0188425.
18. Carlson, K.M., et al., Characterization of the zebrafish atxn1/axh gene family. J Neurogenet, 2009. 23(3): p. 313-23.
19. Jorgensen, N.D., et al., Phosphorylation of ATXN1 at Ser776 in the cerebellum. J Neurochem, 2009. 110(2): p. 675-86.
20. Jorgensen, N.D., et al., Hsp70/Hsc70 regulates the effect phosphorylation has on stabilizing ataxin-1. J Neurochem, 2007. 102(6): p. 2040-8.
21. Lai, S., et al., 14-3-3 Binding to ataxin-1(ATXN1) regulates its dephosphorylation at Ser-776 and transport to the nucleus. J Biol Chem, 2011. 286(40): p. 34606-16.
22. Perez Ortiz, J.M., et al., Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model. Neurobiol Dis, 2018. 116: p. 93-105.
23. Jacobsen, P.F., D.J. Jenkyn, and J.M. Papadimitriou, Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol, 1985. 44(5): p. 472-85.
24. Noda, T. and Y. Ohsumi, Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem, 1998. 273(7): p. 3963-6.
25. Blommaart, E.F., et al., Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J Biol Chem, 1995. 270(5): p. 2320-6.
26. Irwin, S., et al., RNA association and nucleocytoplasmic shuttling by ataxin-1. J Cell Sci, 2005. 118(Pt 1): p. 233-42.
27. Sato, S., et al., Single-cell lineage tracking analysis reveals that an established cell line comprises putative cancer stem cells and their heterogeneous progeny. Sci Rep, 2016. 6: p. 23328.
28. Costanzo, M., et al., Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes. J Cell Sci, 2013. 126(Pt 16): p. 3678-85.
29. Zhu, S., et al., Prion aggregates transfer through tunneling nanotubes in endocytic vesicles. Prion, 2015. 9(2): p. 125-35.
30. Abounit, S., et al., Tunneling nanotubes spread fibrillar alpha-synuclein by intercellular trafficking of lysosomes. EMBO J, 2016. 35(19): p. 2120-2138.
31. Abounit, S., et al., Tunneling nanotubes: A possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. Prion, 2016. 10(5): p. 344-351.
32. Dieriks, B.V., et al., alpha-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients. Sci Rep, 2017. 7: p. 42984.
33. Chastagner, P., et al., Fate and propagation of endogenously formed Tau aggregates in neuronal cells. EMBO Mol Med, 2020. 12(12): p. e12025.
34. Dilsizoglu Senol, A., et al., Effect of tolytoxin on tunneling nanotube formation and function. Sci Rep, 2019. 9(1): p. 5741.
35. Victoria, G.S. and C. Zurzolo, The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases. J Cell Biol, 2017. 216(9): p. 2633-2644.
36. Rostami, J., et al., Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes. J Neurosci, 2017. 37(49): p. 11835-11853.
37. Vilette, D., et al., Cellular mechanisms responsible for cell-to-cell spreading of prions. Cell Mol Life Sci, 2018. 75(14): p. 2557-2574.
38. Kaytor, M.D., et al., A cell-based screen for modulators of ataxin-1 phosphorylation. Hum Mol Genet, 2005. 14(8): p. 1095-105.
39. Lagalwar, S. and H.T. Orr, Regulation of ataxin-1 phosphorylation and its impact on biology. Methods Mol Biol, 2013. 1010: p. 201-9.
40. Fu, H., R.R. Subramanian, and S.C. Masters, 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol, 2000. 40: p. 617-47.
41. Athwal, G.S., et al., Modulation of 14-3-3 protein interactions with target polypeptides by physical and metabolic effectors. Plant Cell Physiol, 2000. 41(4): p. 523-33.
42. Dou, Z., et al., Mammalian autophagy degrades nuclear constituents in response to tumorigenic stress. Autophagy, 2016. 12(8): p. 1416-7.
43. Vig, P.J., et al., Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice. Cerebellum, 2009. 8(3): p. 231-44.
44. Jucker, M. and L.C. Walker, Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci, 2018. 21(10): p. 1341-1349.
45. Jaunmuktane, Z. and S. Brandner, Invited Review: The role of prion-like mechanisms in neurodegenerative diseases. Neuropathol Appl Neurobiol, 2020. 46(6): p. 522-545.
46. Rustom, A., Hen or egg?: some thoughts on tunneling nanotubes. Ann N Y Acad Sci, 2009. 1178: p. 129-36.
47. Gerdes, H.H., N.V. Bukoreshtliev, and J.F. Barroso, Tunneling nanotubes: a new route for the exchange of components between animal cells. FEBS Lett, 2007. 581(11): p. 2194-201.
48. Gurke, S., J.F. Barroso, and H.H. Gerdes, The art of cellular communication: tunneling nanotubes bridge the divide. Histochem Cell Biol, 2008. 129(5): p. 539-50.
49. Gerdes, H.H. and R.N. Carvalho, Intercellular transfer mediated by tunneling nanotubes. Curr Opin Cell Biol, 2008. 20(4): p. 470-5.
50. Baluska, F., et al., Getting connected: actin-based cell-to-cell channels in plants and animals. Trends Cell Biol, 2004. 14(8): p. 404-8.